Paul Reider Coherus Bio Sciences, Inc. (CHRS) insider trading activity

CHRS Quotes by TradingView

Paul Reider is Chief Commercial Officer of Coherus BioSciences, Inc.. Currently has a direct ownership of 81,277 shares of CHRS, which is worth approximately $140,609. The most recent transaction as insider was on Jan 20, 2024, when has been sold 4,854 shares (Common Stock) at a price of $2.44 per share, resulting in proceeds of $11,843. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.3K
0% 3M change
6.64% 12M change
Total Value Held $140,609

Paul Reider Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 20 2024
SELL
Payment of exercise price or tax liability
$11,843 $2.44 p/Share
4,854 Reduced 5.64%
81,277 Common Stock
Jan 04 2024
SELL
Payment of exercise price or tax liability
$6,643 $2.92 p/Share
2,275 Reduced 2.57%
86,131 Common Stock
Dec 13 2023
SELL
Payment of exercise price or tax liability
$4,856 $2.37 p/Share
2,049 Reduced 2.27%
88,406 Common Stock
Apr 01 2023
SELL
Payment of exercise price or tax liability
$16,764 $6.84 p/Share
2,451 Reduced 2.74%
87,053 Common Stock
PR

Paul Reider

Chief Commercial Officer
Redwood City, CA

Track Institutional and Insider Activities on CHRS

Follow Coherus BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CHRS shares.

Notify only if

Insider Trading

Get notified when an Coherus Bio Sciences, Inc. insider buys or sells CHRS shares.

Notify only if

News

Receive news related to Coherus BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CHRS